200 related articles for article (PubMed ID: 19588926)
1. Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling.
Obungu VH; Gelfanova V; Rathnachalam R; Bailey A; Sloan-Lancaster J; Huang L
Biochemistry; 2009 Aug; 48(30):7251-60. PubMed ID: 19588926
[TBL] [Abstract][Full Text] [Related]
2. Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions.
Bajorath J
Proteins; 1999 Jun; 35(4):475-82. PubMed ID: 10382675
[TBL] [Abstract][Full Text] [Related]
3. IL-1beta epitope mapping using site-directed mutagenesis and hydrogen-deuterium exchange mass spectrometry analysis.
Lu J; Witcher DR; White MA; Wang X; Huang L; Rathnachalam R; Beals JM; Kuhstoss S
Biochemistry; 2005 Aug; 44(33):11106-14. PubMed ID: 16101294
[TBL] [Abstract][Full Text] [Related]
4. Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: structural insights into Fas/Fas ligand interaction.
Nisihara T; Ushio Y; Higuchi H; Kayagaki N; Yamaguchi N; Soejima K; Matsuo S; Maeda H; Eda Y; Okumura K; Yagita H
J Immunol; 2001 Sep; 167(6):3266-75. PubMed ID: 11544314
[TBL] [Abstract][Full Text] [Related]
5. The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells.
Kirkin V; Cahuzac N; Guardiola-Serrano F; Huault S; Lückerath K; Friedmann E; Novac N; Wels WS; Martoglio B; Hueber AO; Zörnig M
Cell Death Differ; 2007 Sep; 14(9):1678-87. PubMed ID: 17557115
[TBL] [Abstract][Full Text] [Related]
6. A proteomic screen reveals novel Fas ligand interacting proteins within nervous system Schwann cells.
Thornhill PB; Cohn JB; Drury G; Stanford WL; Bernstein A; Desbarats J
FEBS Lett; 2007 Sep; 581(23):4455-62. PubMed ID: 17761170
[TBL] [Abstract][Full Text] [Related]
7. Epitope mapping of antibodies by mass spectroscopy: a case study.
Obungu VH; Gelfanova V; Huang L
Methods Mol Biol; 2013; 988():291-302. PubMed ID: 23475727
[TBL] [Abstract][Full Text] [Related]
8. Differential protein-protein interactions of full length human FasL and FasL fragments generated by proteolysis.
Lettau M; Voss M; Ebsen H; Kabelitz D; Janssen O
Exp Cell Res; 2014 Jan; 320(2):290-301. PubMed ID: 24291222
[TBL] [Abstract][Full Text] [Related]
9. [The expression and application of human Fas ligand in E.coli].
Li NL; Nie H; Yu QW; Bo J; Ma AL; Zhang JY; Shen BH; Wang L; Zhang DQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):20-2. PubMed ID: 15132896
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping by mass spectrometry: determination of an epitope on HIV-1 IIIB p26 recognized by a monoclonal antibody.
Parker CE; Papac DI; Trojak SK; Tomer KB
J Immunol; 1996 Jul; 157(1):198-206. PubMed ID: 8683115
[TBL] [Abstract][Full Text] [Related]
11. Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal antibody epitope mapping and molecular modeling.
Giri TK; Villoutreix BO; Wallqvist A; Dahlbäck B; de Frutos PG
Thromb Haemost; 1998 Nov; 80(5):798-804. PubMed ID: 9843174
[TBL] [Abstract][Full Text] [Related]
12. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
Nuss JM; Air GM
J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
[TBL] [Abstract][Full Text] [Related]
13. A novel Fas ligand in mollusk abalone: molecular characterization, immune responses and biological activity of the recombinant protein.
De Zoysa M; Nikapitiya C; Moon DO; Whang I; Kim GY; Lee J
Fish Shellfish Immunol; 2009 Sep; 27(3):423-32. PubMed ID: 19576285
[TBL] [Abstract][Full Text] [Related]
14. The antigen binding sites of various hCG monoclonal antibodies show homology to different domains of LH receptor.
Gadkari RA; Sandhya S; Sowdhamini R; Dighe RR
Mol Cell Endocrinol; 2007 Jan; 260-262():23-32. PubMed ID: 17045394
[TBL] [Abstract][Full Text] [Related]
15. Epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for tumor inhibitory mechanism.
Hu S; Zhu Z; Li L; Chang L; Li W; Cheng L; Teng M; Liu J
Proteins; 2008 Feb; 70(3):938-49. PubMed ID: 17847085
[TBL] [Abstract][Full Text] [Related]
16. Identification of immunodominant regions of Brassica juncea glyoxalase I as potential antitumor immunomodulation targets.
Deswal R; Singh R; Lynn AM; Frank R
Peptides; 2005 Mar; 26(3):395-404. PubMed ID: 15652645
[TBL] [Abstract][Full Text] [Related]
17. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
[TBL] [Abstract][Full Text] [Related]
18. The adaptor protein Grb2 regulates cell surface Fas ligand in Schwann cells.
Thornhill PB; Cohn JB; Stanford WL; Desbarats J
Biochem Biophys Res Commun; 2008 Nov; 376(2):341-6. PubMed ID: 18789888
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
[TBL] [Abstract][Full Text] [Related]
20. Generation of rabbit antibodies against death ligands by cDNA immunization.
Diestre C; Martínez-Lorenzo MJ; Bosque A; Naval J; Larrad L; Anel A
J Immunol Methods; 2006 Dec; 317(1-2):12-20. PubMed ID: 17045605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
